METTL14 and cancer: Inhibition of METTL14 not only promoted the proliferation and accumulation of cytotoxic tumor-infiltrating CD8 + T cells, but also induced the secretion of IFN-C, CXCL9, and CXCL10, thus enhanced immunotherapy efficacy and suppressed cancer proliferation [108].